Management's stated H2 direction is ESS-led revenue expansion with sustained profitability.
On the second-quarter call, EVP Oh Jae-kyun said H2 revenue would rise sharply on US grid-scale ESS and UPS demand, with profitability staying healthy thanks to new LFP line operations and the Advanced Manufacturing Production Credit (AMPC). Production timing has also been specified.
US ESS LFP cells are set to enter mass production in October with customer shipments starting within the year, and management said quality validation of the US prismatic LFP line was under way.
On orders, EVP Cho Yong-hwi said US ESS orders secured so far cover a substantial portion of capacity through 2029, that including projects likely to be won in H2 demand would exceed capacity from 2028, and that additional capacity options are under internal review.
In small cells, EVP Cho Han-je projected UPS and BBU battery revenue each to grow more than 70% year on year in 2026 and put the company's share of those markets at roughly 40-50%.
On next-generation technology, the company said all-solid-state batteries remain on track for mass production in the second half of 2027, that the first commercialization project is likely to be humanoids, and that humanoid samples would be supplied during H2.
On utilization, the first-quarter briefing indicated Hungary plant utilization improving to above 70% in H2, versus a reported 40%-range rate for the Hungarian prismatic lines in 4Q25.
On funding, the board approved transferring 13,088,235 Samsung Display common shares at KRW 340,000 each for a total of KRW 4,450bn, with a scheduled transfer date of August 27, while the company said existing investment plans will change following the Synergy Cells solo-entity conversion but that specifics are not yet fixed and will be disclosed when confirmed.